Dantzer Jennifer A, Kim Edwin H
Johns Hopkins University School of Medicine, Division of Pediatric Allergy, Immunology, and Rheumatology, Baltimore, Md.
University of North Carolina School of Medicine, Division of Pediatric Allergy and Immunology, Chapel Hill, NC.
J Allergy Clin Immunol Pract. 2024 Mar;12(3):546-552. doi: 10.1016/j.jaip.2023.10.018. Epub 2023 Oct 16.
Food allergy is an increasing public health problem in children and adults. In addition to the risk of potentially severe reactions, food allergy can have a significant burden on quality of life, nutrition, cost of living, and social activities. Traditionally, treatment has primarily included strict food allergen avoidance and use of emergency medications to treat an allergic reaction. However, in recent years, there have been significant strides in the advancement of food allergy treatment, including the approval of the first and only approved therapy (peanut oral immunotherapy) for food allergy in 2020. Clinical trials have primarily focused on food allergen immunotherapy (oral, epicutaneous, sublingual). Building off of a foundation of promising data supporting the efficacy of food oral immunotherapy and our greater understanding of the underlying mechanism of immunotherapy, newer approaches, including alternative routes of delivery, adjuncts to therapy, modified allergens, and utilization in younger patients, aim to provide safer and more effective treatment approaches to the millions of patients burdened by food allergy.
食物过敏在儿童和成人中是一个日益严重的公共卫生问题。除了有潜在严重反应的风险外,食物过敏会对生活质量、营养、生活成本和社交活动造成重大负担。传统上,治疗主要包括严格避免食物过敏原以及使用应急药物来治疗过敏反应。然而,近年来,食物过敏治疗取得了重大进展,包括2020年首个也是唯一获批的食物过敏治疗方法(花生口服免疫疗法)获得批准。临床试验主要集中在食物过敏原免疫疗法(口服、经皮、舌下)。基于支持食物口服免疫疗法疗效的有前景的数据基础以及我们对免疫疗法潜在机制的更深入理解,新的方法,包括替代给药途径、治疗辅助手段、改良过敏原以及在更年轻患者中的应用,旨在为数百万受食物过敏困扰的患者提供更安全、更有效的治疗方法。